These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 11765596)
1. Pharmacokinetics of zidovudine following intravenous bolus administration of a novel niosome preparation devoid of cholesterol. Gopinath D; Ravi D; Karwa R; Rao BR; Shashank A; Rambhau D Arzneimittelforschung; 2001 Nov; 51(11):924-30. PubMed ID: 11765596 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and tissue distribution of zidovudine in rats following intravenous administration of zidovudine myristate loaded liposomes. Jin SX; Bi DZ; Wang J; Wang YZ; Hu HG; Deng YH Pharmazie; 2005 Nov; 60(11):840-3. PubMed ID: 16320946 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and tissue distribution of (+/-)-3'-azido-2',3'-dideoxy-5'-O-(2-bromomyristoyl)thymidine, a prodrug of 3'-azido-2',3'-dideoxythymidine (AZT) in mice. Parang K; Wiebe LI; Knaus EE J Pharm Pharmacol; 1998 Sep; 50(9):989-96. PubMed ID: 9811159 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, in vitro and in vivo release kinetics, and anti-HIV activity of a sustained-release prodrug (mPEG-AZT) of 3'-azido-3'-deoxythymidine (AZT, Zidovudine). Li W; Chang Y; Zhan P; Zhang N; Liu X; Pannecouque C; De Clercq E ChemMedChem; 2010 Nov; 5(11):1893-8. PubMed ID: 20936623 [TBL] [Abstract][Full Text] [Related]
5. Transplacental pharmacokinetics and fetal distribution of azidothymidine, its glucuronide, and phosphorylated metabolites in late-term rhesus macaques after maternal infusion. Patterson TA; Binienda ZK; Lipe GW; Gillam MP; Slikker W; Sandberg JA Drug Metab Dispos; 1997 Apr; 25(4):453-9. PubMed ID: 9107545 [TBL] [Abstract][Full Text] [Related]
6. A novel anti-HIV dextrin-zidovudine conjugate improving the pharmacokinetics of zidovudine in rats. Wannachaiyasit S; Chanvorachote P; Nimmannit U AAPS PharmSciTech; 2008; 9(3):840-50. PubMed ID: 18626772 [TBL] [Abstract][Full Text] [Related]
7. Comparative pharmacokinetics of 3'-azido-3'-deoxythymidine (AZT) and 3'-azido-2',3'-dideoxyuridine (AZddU) in mice. Doshi KJ; Gallo JM; Boudinot FD; Schinazi RF; Chu CK Drug Metab Dispos; 1989; 17(6):590-4. PubMed ID: 2575492 [TBL] [Abstract][Full Text] [Related]
8. Improved body distribution of 14C-labelled AZT bound to nanoparticles in rats determined by radioluminography. Löbenberg R; Maas J; Kreuter J J Drug Target; 1998; 5(3):171-9. PubMed ID: 9606007 [TBL] [Abstract][Full Text] [Related]
9. Self-assembled drug delivery systems. Part 5: self-assemblies of a bolaamphiphilic prodrug containing dual zidovudine. Jin Y; Qi N; Tong L; Chen D Int J Pharm; 2010 Feb; 386(1-2):268-74. PubMed ID: 19941945 [TBL] [Abstract][Full Text] [Related]
10. [The distribution of azidothymidine palmitate galactosylated liposomes in mice]. Wu HB; Deng YH; Wang SN; Zhou XY; Wang N; Shi L Yao Xue Xue Bao; 2007 May; 42(5):538-44. PubMed ID: 17703780 [TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo pharmacokinetic characterization of two novel prodrugs of zidovudine. Quevedo MA; Briñón MC Antiviral Res; 2009 Aug; 83(2):103-11. PubMed ID: 19549583 [TBL] [Abstract][Full Text] [Related]
12. Effect of probenecid on the renal and nonrenal clearances of zidovudine and its distribution into cerebrospinal fluid in the rabbit. Hedaya MA; Sawchuk RJ J Pharm Sci; 1989 Sep; 78(9):716-22. PubMed ID: 2585262 [TBL] [Abstract][Full Text] [Related]
13. Tissue distribution, pharmacokinetics and stability studies of zidovudine delivered by niosomes and proniosomes. Ruckmani K; Sankar V; Sivakumar M J Biomed Nanotechnol; 2010 Feb; 6(1):43-51. PubMed ID: 20499831 [TBL] [Abstract][Full Text] [Related]
14. Metabolism and pharmacokinetics of the combination Zidovudine plus Lamivudine in the adult Erythrocebus patas monkey determined by liquid chromatography-tandem mass spectrometric analysis. Divi RL; Doerge DR; Twaddle NC; Shockley ME; St Claire MC; Harbaugh JW; Harbaugh SW; Poirier MC Toxicol Appl Pharmacol; 2008 Jan; 226(2):206-11. PubMed ID: 17949768 [TBL] [Abstract][Full Text] [Related]
15. Intracellular metabolism and pharmacokinetics of 5'-hydrogenphosphonate of 3'-azido-2',3'-dideoxythymidine, a prodrug of 3'-azido-2',3'-dideoxythymidine. Skoblov Y; Karpenko I; Shirokova E; Popov K; Andronova V; Galegov G; Kukhanova M Antiviral Res; 2004 Aug; 63(2):107-13. PubMed ID: 15302139 [TBL] [Abstract][Full Text] [Related]
16. The effect of dihydronicotinate N-substitution on the brain-targeting efficacy of a zidovudine chemical delivery system. Brewster ME; Pop E; Braunstein AJ; Pop AC; Druzgala P; Dinculescu A; Anderson W; Elkoussi A; Bodor N Pharm Res; 1993 Sep; 10(9):1356-62. PubMed ID: 8234177 [TBL] [Abstract][Full Text] [Related]
17. Body distribution of azidothymidine bound to hexyl-cyanoacrylate nanoparticles after i.v. injection to rats. Löbenberg R; Araujo L; von Briesen H; Rodgers E; Kreuter J J Control Release; 1998 Jan; 50(1-3):21-30. PubMed ID: 9685869 [TBL] [Abstract][Full Text] [Related]
18. Targeting of 3'-azido 3'-deoxythymidine (AZT)-loaded poly(isohexylcyanoacrylate) nanospheres to the gastrointestinal mucosa and associated lymphoid tissues. Dembri A; Montisci MJ; Gantier JC; Chacun H; Ponchel G Pharm Res; 2001 Apr; 18(4):467-73. PubMed ID: 11451033 [TBL] [Abstract][Full Text] [Related]
19. Improved Safety, Bioavailability and Pharmacokinetics of Zidovudine through Lactoferrin Nanoparticles during Oral Administration in Rats. Kumar P; Lakshmi YS; C B; Golla K; Kondapi AK PLoS One; 2015; 10(10):e0140399. PubMed ID: 26461917 [TBL] [Abstract][Full Text] [Related]
20. Transdermal delivery system for zidovudine: in vitro, ex vivo and in vivo evaluation. Narishetty ST; Panchagnula R Biopharm Drug Dispos; 2004 Jan; 25(1):9-20. PubMed ID: 14716748 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]